AMRUTANJAN · Healthcare · Drug Manufacturers - Specialty & Generic
Composite scorecard: 40/100 — Quality 48 · Valuation 54 · Momentum 0
| Share price | ₹546.65 |
| Market cap | ₹1,555 Cr |
| P/E ratio | 26.7 |
| P/B ratio | 4.2 |
| ROCE | 20.4% |
| Dividend yield | 1.04% |
| Book value | ₹128.04 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹503 Cr | ₹58 Cr | 12.3% |
| 2025 | ₹452 Cr | ₹51 Cr | 11.4% |
| 2024 | ₹420 Cr | ₹45 Cr | 11.4% |
| 2023 | ₹378 Cr | ₹40 Cr | 11.1% |
| 2022 | — | — | — |
Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms and women hygiene products in India and internationally. It operates through OTC Products, Beverages, Women's Hygiene, and Others segments. The company provides pain management products comprising pain balms and roll-ons, back pain roll-ons, stick-on patch, and joint muscle sprays; dental pain gel; and decorn corn caps; hand sanitizer under the NOGerms brand name; and fruit and rehydration juice drinks under the Fruitnik brand name. The company also offers congestion management products that consists of cold